Efficacy and mechanism of action of an anti-HCV ribozyme. Treatment of cells infected with HCV-poliovirus, using a ribozyme (HEPTAZYME) directed at site 195 of the HCV genome, results in a significant, approximately 90% inhibition of replication (P < 0.01), while treatment with either a SAC or a BAC results in no inhibition of viral replication.